I Ray-Coquard

Dostarlimab and niraparib in primary gevorderd ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-12

Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.

European journal of cancer (Oxford, England : 1990) · 25 juli 2025

Efficacy of subsequent therapies in patiënten met gevorderd ovarian cancer who relapse after eerstelijns olaparib mai...

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-02

Olaparib-rechallenge als onderhoud bij recidief ovariumcarcinoom na eerdere PARP: OReO/ENGOT-ov38 langetermijn

Annals of oncology : official journal of the European Society for Medical Oncology · 2023-12

Olaparib plus bevacizumab onderhoud bij ovariumcarcinoom: PAOLA-1 definitieve OS

Annals of oncology : official journal of the European Society for Medical Oncology · 2023-08

Trabectedine versus BSC bij eerder behandeld wekedelensarcoom: fase III

Annals of oncology : official journal of the European Society for Medical Oncology · 2021-08

ESMO aanbevelingen voor HRD-testen en PARP-remmerbehandeling

Annals of oncology : official journal of the European Society for Medical Oncology · 2020-12

Prognostische genexpressiesignatuur bij hooggradige sereuze ovariumcarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2020-09

ESMO-ESGO consensus over ovariumcarcinoom: pathologie, moleculaire biologie en stadiëring

Annals of oncology : official journal of the European Society for Medical Oncology · 1 mei 2019

Niet-epitheliaal ovariumcarcinoom: ESMO-richtlijn

Annals of oncology : official journal of the European Society for Medical Oncology · 1 oktober 2018

Lifastuzumab vedotin versus PLD bij platinaresistent ovariumcarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 1 april 2018

PM01183 (lurbinectedin) versus topotecan bij platinaresistent ovariumcarcinoom: fase II-studie

Annals of oncology : official journal of the European Society for Medical Oncology · 1 juni 2017

Gezondheidsgerelateerde kwaliteit van leven bij recidief ovariumcarcinoom onder paclitaxel plus trebananib: TRINOVA-1-studie

Annals of oncology : official journal of the European Society for Medical Oncology · 2016-06